Peter Attia· MD
the risk that e4 genotype carries compared to the others and the fact that e4 homozygotes have higher risk and also different responses to cardiovascular meds different different risks for other diseases besides dementia
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
the risk that e4 genotype carries compared to the others and the fact that e4 homozygotes have higher risk and also different responses to cardiovascular meds different different risks for other diseases besides dementia
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
the risk that e4 genotype carries compared to the others and the fact that e4 homozygotes have higher risk and also different responses to cardiovascular meds different different risks for other diseases besides dementia
so what's really obvious when looking at this is that the 4 4 has a significantly higher risk than everything else
the apoe4 alil it's a genetic variation that is known to increase the risk of Alzheimer's disease and dementia